Nestlé S.A. (NSRGY)

OTCMKTS: NSRGY · Delayed Price · USD
103.94
-0.73 (-0.70%)
May 22, 2024, 4:00 PM EDT - Market closed
Market Cap 265.50B
Revenue 101.99B
Net Income 12.57B
Shares Out 2.55B
EPS 4.62
PE Ratio 22.46
Forward PE 18.32
Dividend $3.41 (3.28%)
Ex-Dividend Date Apr 22, 2024
Volume 701,483
Open 103.51
Previous Close 104.67
Day's Range 103.37 - 104.07
52-Week Range 99.04 - 125.41
Beta 0.29
Analysts n/a
Price Target n/a
Earnings Date n/a

About NSRGY

Nestlé S.A., together with its subsidiaries, operates as a food and beverage company. The company operates through Zone North America; Zone Europe; Zone Asia, Oceania, and Africa; Zone Latin America; Zone Greater China; Nespresso; and Nestlé Health Science segments. It offers baby foods under the Cerelac, Gerber, Nido, and NaturNes brands; bottled water under the Nestlé Pure Life, Perrier, Vittel, Buxton, Erikli, and S.Pellegrino brands; cereals under the Fitness, Nesquik, cheerios, and Lion Cereals brands; and chocolate and confectionery produ... [Read more]

Industry Packaged Foods
Founded 1866
Employees 270,000
Stock Exchange OTCMKTS
Ticker Symbol NSRGY
Full Company Profile

Financial Performance

In 2023, Nestlé's revenue was 93.35 billion, a decrease of -1.51% compared to the previous year's 94.78 billion. Earnings were 11.51 billion, an increase of 19.94%.

Financial numbers in CHF Financial Statements

News

Nestle announces Vital Pursuit frozen-food brand targeting GLP-1 users

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss Nestle's new frozen food brand, whether Americans should eat this food, and more.

17 hours ago - CNBC Television

Nestlé caters to the Ozempic crowd with a line of frozen meals crafted just for GLP-1 users

GLP-1 weight-loss drugs like Ozempic and Wegovy, once prescribed only to people managing conditions like diabetes, have hit the mainstream. Not only are celebrities slimming down with the injections b...

19 hours ago - Fast Company

Nestlé launches food line targeting Ozempic, other weight-loss drug users

Nestlé is launching a line of food products tailored to people using weight-loss medication in an effort to capitalize on a market expected to reach $30 billion in the next six years.

1 day ago - New York Post

Ozempic users will soon get their own heat-and-eat meals

A new line of frozen foods will cater to users of weight loss drugs like Ozempic and Wegovy. Nestlé's Vital Pursuit brand will include sandwiches and bowls.

1 day ago - Business Insider

Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users

Nestle's Vital Pursuit brand's initial lineup of 12 items will include frozen bowls with whole grains or protein pasta, sandwich melts and pizzas.

1 day ago - CNBC

Nestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users

Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as Wegovy or Ozempic for weight ...

1 day ago - Reuters

Nestle's Nescafe to invest $196 million in Brazil by 2026 to tap surging demand

Nestle plans to invest 1 billion reais ($196.5 million) in Brazil by 2026 to expand production capacity and out-of-home sales of its Nescafe lines, targeting younger consumers, executives told Reuters...

13 days ago - Reuters

Dr Reddy's Laboratories' CEO says Nestle has an 'amazing portfolio'

Erez Israeli, CEO of Dr Reddy's Laboratories, discusses its joint venture with Nestle India.

14 days ago - CNBC International TV

Unilever, Nestle slow price rises but the struggle for consumers remains

While price rises are starting to slow for companies like Nestle and Unilever after months of heading higher, the battle to win back consumers is far from over.

Other symbols: UL
27 days ago - Market Watch

Nestle Sales Growth Slows Sharply on Consumer Uncertainty

Nestle's first-quarter organic sales missed forecasts as consumer demand remained weak, particularly in North America, while supply-chain disruptions continued to hold back volumes.

27 days ago - WSJ

Nestle India unit's profit beats estimates on higher demand

Nestle India reported a bigger-than-expected increase in its quarterly profit on Thursday, as it benefited from higher product prices and demand for its packaged food items.

27 days ago - Reuters

These are the factors driving cocoa prices to all-time highs

CNBC's Frank Holland discusses the factors fueling cocoa's price increases and which commodity appears to be next for a surge.

Other symbols: HSYMDLZ
4 weeks ago - CNBC Television

Indian food regulator begins enquiry into Nestle over alleged sugar use in baby foods, ET reports

The Indian food regulator has started an enquiry into Nestle India over the alleged use of sugar in baby food products in low-income countries, including India, by its Swiss parent, the Economic Times...

4 weeks ago - Reuters

Meet Europe's Mag 18. Novo Nordisk Stock, ASML, and Others Can Rival the Mag Seven.

The Mag Seven stocks have powered gains in the U.S. market. Now, the hunt is on for an equivalent group of outperformers elsewhere.

6 weeks ago - Barrons

Mondelez, Hershey, Nestle stocks retreat as cocoa prices surge

Mondelez, Hershey, and Nestle stock prices have retreated as concerns about the cocoa market intensified. Nestle, the giant Swiss giant, retreated to CHF 95.55 on Thursday, 18% below its highest level...

Other symbols: HSYMDLZ
7 weeks ago - Invezz

‘GRANOLAS' vs. the Magnificent Seven: Which should you dig into now?

Wall Street loves a good story, as evidenced by the recent focus on a group of stocks called the “GRANOLAS.” These are a group of 11 European stocks that have led Europe's stock markets higher.

2 months ago - Market Watch

Food price inflation is set to fall but volatility will remain, Nestle CEO

Nestle CEO Mark Schneider says food price inflation is falling but "choppiness" will continue as certain commodity prices remain at record highs. He adds that "aspirational brands" are still popular a...

3 months ago - CNBC International TV

Nestle, Danone see price hikes slowing after years of sharp increases

Two of the world's top consumer goods companies, Danone and Nestle, said on Thursday they will slow price increases in 2024 after two years of hikes that have prompted shoppers to seek cheaper alterna...

3 months ago - Reuters

Nestle Warns on Sales Growth as Inflation Continues to Bite

Nestle reported full-year earnings and sales that were just shy of expectations, and cautioned that sales growth will moderate this year as higher prices force shoppers to ease spending.

3 months ago - WSJ

Nestle misses full-year organic sales estimates as price hikes deter shoppers

Nestle reported full-year organic sales growth slightly below expectations on Thursday as the world's biggest packaged food company continued to hike prices, prompting some shoppers to turn to competi...

3 months ago - Reuters

To hike or not to hike? Nestle results to reveal impact of raising prices

As Nestle, the world's largest food company, prepares to publish its full-year results on Thursday, analysts will be seeking to work out the real impacts of the Nescafe coffee owner's push to raise it...

3 months ago - Market Watch

3 Undervalued Stocks to Buy Before the Big Game

#Morningstar  #Volkswagen #StockInvesting The cheap stocks of these game-day advertisers look like solid long-term investments. 00:00 Introduction 00:55 Anheuser-Busch InBev BUD 01:30 Volkswagen VWAGY...

Other symbols: BUDVWAGY
3 months ago - Morningstar

Nestlé's Steve Presley: 2024 is about getting back to innovation

Steve Presley is CEO of Nestlé's Zone North America.  He says 2024 will mark a return to innovation and doing more around marketing for its many brands.

5 months ago - Business Insider

Nestle CEO says weight-loss drugs no threat to coffee business

ZURICH, Dec 20 (Reuters) - Nestle (NESN.S) sees no threat to its huge coffee business from the rising popularity of weight-loss drugs like Eli Lilly's (LLY.N) Zepbound and Novo Nordisk's (NOVOb.CO) We...

5 months ago - Reuters

Nestle CEO Schneider: See Turbulent Environment Remaining

Nestlé Chief Executive Officer Mark Schneider discusses the inflationary environment, the impact of weight-loss drugs to its business and packing waste. He speaks with Bloomberg's Francine Lacqua on "...

5 months ago - Bloomberg Markets and Finance